Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (IDENTIFY)
Status
Completed
Conditions
Stage IIIB/IV
Non-Small Cell Lung Cancer
Details and patient eligibility
About
The purpose of this trial is to compare the evolution of patients receiving first line treatment for locally advanced or metastatic lung cancer, taking into account if they were requested or not the EGFR mutation test as part of the diagnosis and treatment strategy. There is no assignment to any particular therapeutic strategy.
Full description
Study of cases and controls on diagnosis and treatment strategies in patients with NSCLC with or without EGFR mutations.
Enrollment
450 estimated patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Patients with confirmed diagnosis of lung adenocarcinoma, stage IIIb/IV.
- Patients under 1st line treatment against lung adenocarcinoma.
Exclusion criteria
- Patients not having the information required by the protocol.
Trial design
450 participants in 2 patient groups
Case
Control
Trial contacts and locations
17
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems